HIRSCHMAN ORIN 13D and 13G filings for NeuBase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-05-01 4:17 pm Purchase |
2019-07-12 | 13G | NeuBase Therapeutics, Inc. NBSE |
HIRSCHMAN ORIN | 28,199 2.440% |
28,199 (New Position) |
Filing |